SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA: CLINICAL EXOME PANEL (Sec. & CNVs) – 3 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Malignant Hyperthermia Susceptibility Panel is designed to detect genetic variants associated with this potentially fatal pharmacogenetic reaction, triggered by volatile anesthetics or depolarizing muscle relaxants. Malignant hyperthermia is characterized by hypercapnia, muscle rigidity, tachycardia, metabolic acidosis, and rapidly progressive hyperthermia during general anesthesia. Identifying mutations in genes encoding calcium channels and proteins related to muscle contraction allows for the assessment of individual risk of developing the disease, guides anesthetic selection, and enables the implementation of preventive measures. Genes analyzed: RYR1, CACNA1S, STAC3. You can consult the complete list of analyzed genes by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€